Patients Have Many Fears, Misconceptions About Radiation Therapy

Breast Cancer News

Patients Have Many Fears, Misconceptions About Radiation Therapy
Malignant Breast NeoplasmBreast CarcinomaRadiation Therapy
  • 📰 Medscape
  • ⏱ Reading Time:
  • 27 sec. here
  • 24 min. at publisher
  • 📊 Quality Score:
  • News: 91%
  • Publisher: 55%

A recent survey revealed that many patients were worried about the physical effects of radiation, and more than one third were concerned about the financial cost.

A cross-sectional survey of patients preparing for their first radiation therapy consultation found that many patients worried about the physical effects of radiation therapy , including pain, memory loss, and nausea, and more than 60% said they were concerned about their ability to perform daily activities.

The patients completed a 30-question electronic survey about radiation therapy perceptions and fears or concerns prior to their initial radiation consultation. Patients expressed concerns about the impact radiation therapy would have on daily activities, with 62% reporting being moderately or very concerned about their ability to perform daily activities and 37% worried about their ability to continue working. Other concerns included the ability to exercise , financial cost , and transportation to treatment sessions .

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

Malignant Breast Neoplasm Breast Carcinoma Radiation Therapy Radiotherapy Radiation Oncology Lung Cancer Lung Carcinoma Cancer Of The Lung Toxicology Toxicity Poisoning Toxins Pain Management Patient Safety Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm Cancer Pain Pain From Cancer Cancer-Related Pain Healthcare And Medical Technology

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

West Virginia Halts Coverage of Weight Loss Drugs, Sparking Fears for PatientsWest Virginia Halts Coverage of Weight Loss Drugs, Sparking Fears for PatientsA pilot program in West Virginia covering weight loss drugs for public employees has been abruptly halted, leaving patients like Lory Osborn facing anxiety about running out of medication and potentially regaining lost weight. The program's suspension comes amid a nationwide debate about the cost-effectiveness of these drugs, with other insurers also facing similar dilemmas. The federal government is considering covering these drugs for millions of patients on Medicaid and Medicare, but the proposal faces potential opposition.
Read more »

Patients Before Monopolies Act: A Game Changer for Patients, Pharmacists, and Prices?Patients Before Monopolies Act: A Game Changer for Patients, Pharmacists, and Prices?The act would prohibit pharmacy benefit managers and pharmacies from being under common ownership, potentially creating a more equitable and competitive healthcare landscape.
Read more »

Corridor Care: Hospitals Overflowing as Patients Face Dilapidated ConditionsCorridor Care: Hospitals Overflowing as Patients Face Dilapidated ConditionsHospitals across the UK are overwhelmed, leading to patients being treated in corridors, bathrooms, and even car parks. The Royal College of Nursing (RCN) reports heartbreaking stories of patients dying in these makeshift areas, pregnant women miscarrying in side rooms, and elderly patients left in soiled clothing for days. Nurses warn that the lack of space and resources is putting patients at risk, hindering their ability to provide proper care and access essential equipment like oxygen and heart monitors.
Read more »

Xanomeline/Trospium Shows Cognitive Improvement in Schizophrenia PatientsXanomeline/Trospium Shows Cognitive Improvement in Schizophrenia PatientsA new study found that xanomeline/trospium chloride, a novel M1/M4 muscarinic receptor agonist, significantly improved cognitive function in patients with acute schizophrenia and cognitive impairment. The analysis combined data from two 5-week inpatient phase 3 trials involving 357 adult patients. Patients receiving xanomeline/trospium showed the largest improvement in verbal recognition memory, with additional benefits observed for sustained attention and executive functioning. The treatment effect was most pronounced in patients with more severe baseline cognitive impairment.
Read more »

Rheumatoid Arthritis Linked to Increased Risk of Heart Failure with Preserved Ejection FractionRheumatoid Arthritis Linked to Increased Risk of Heart Failure with Preserved Ejection FractionA study using data from the Mass General Brigham Biobank found that patients with rheumatoid arthritis (RA) have a significantly higher risk of developing heart failure (HF), particularly HF with preserved ejection fraction (HFpEF). The study, which followed patients for a median of 10.3 years, identified that RA patients had a 79% increased risk of HF compared to those without the condition. HFpEF was the predominant HF subtype in both groups, and RA patients experienced a higher incidence of HFpEF. The authors suggest that chronic inflammation associated with RA may contribute to this increased risk.
Read more »

Success in Osteoporosis Research Can Lead to Underrecruitment ChallengesSuccess in Osteoporosis Research Can Lead to Underrecruitment ChallengesA research team in Australia encountered a surprising problem: their successful tracking of osteoporosis patients through medical records actually hindered their ability to recruit participants for a clinical trial. The team, led by Christopher White, PhD, had developed a comprehensive database of over 30,000 patients with osteoporosis and their fracture risks. However, they underestimated the severity of vertebral fractures in some patients, leading to underrecruitment. This experience prompted White to collaborate with other centers facing similar challenges, leveraging AI and AES coding to identify patients at risk for osteoporotic fractures more effectively.
Read more »



Render Time: 2025-02-14 16:38:31